Intracranial Aneurysm Classifier Using Phenotypic Factors: An International Pooled Analysis.
hypertension
intracranial aneurysm
location
risk factors
smoking
subarachnoid hemorrhage
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
30 Aug 2022
30 Aug 2022
Historique:
received:
26
04
2022
revised:
02
08
2022
accepted:
26
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Intracranial aneurysms (IAs) are usually asymptomatic with a low risk of rupture, but consequences of aneurysmal subarachnoid hemorrhage (aSAH) are severe. Identifying IAs at risk of rupture has important clinical and socio-economic consequences. The goal of this study was to assess the effect of patient and IA characteristics on the likelihood of IA being diagnosed incidentally versus ruptured. Patients were recruited at 21 international centers. Seven phenotypic patient characteristics and three IA characteristics were recorded. The analyzed cohort included 7992 patients. Multivariate analysis demonstrated that: (1) IA location is the strongest factor associated with IA rupture status at diagnosis; (2) Risk factor awareness (hypertension, smoking) increases the likelihood of being diagnosed with unruptured IA; (3) Patients with ruptured IAs in high-risk locations tend to be older, and their IAs are smaller; (4) Smokers with ruptured IAs tend to be younger, and their IAs are larger; (5) Female patients with ruptured IAs tend to be older, and their IAs are smaller; (6) IA size and age at rupture correlate. The assessment of associations regarding patient and IA characteristics with IA rupture allows us to refine IA disease models and provide data to develop risk instruments for clinicians to support personalized decision-making.
Identifiants
pubmed: 36143196
pii: jpm12091410
doi: 10.3390/jpm12091410
pmc: PMC9501769
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Commission
ID : FP6-IST-2004-027703
Organisme : Swiss SystemsX.ch initiative
ID : na
Organisme : European Research Council under the European Union's Horizon 2020
ID : na
Organisme : innovation programme PRYSM
ID : 852173
Organisme : Dutch Heart Foundation
ID : CVON2015-08 ERASE
Organisme : NIH Funding
ID : na
Organisme : VaCaRMe program
ID : na
Organisme : Agence Nationale de la Recherche
ID : ANR-15-CE17-0008-01
Organisme : Genavie Foundation
ID : na
Organisme : Société Française de Radiologie and the Société Française de Neuroradiologie
ID : na
Organisme : Spain's Ministry of Health
ID : RD16/0019/0002
Organisme : Spain's Ministry of Health
ID : RD16/0019/0010 INVICTUS-PLUS
Organisme : Spain's Ministry of Health
ID : Instituto de Salud Carlos III FEDER
Organisme : CIHR
ID : na
Pays : Canada
Organisme : Helsinki University Central Hospital EVO
ID : TYH2018316
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
AJNR Am J Neuroradiol. 2019 May;40(5):834-839
pubmed: 30975650
N Engl J Med. 2012 Jun 28;366(26):2474-82
pubmed: 22738097
Neurosurg Focus. 2019 Jul 1;47(1):E9
pubmed: 31261132
Lancet. 2003 Jul 12;362(9378):103-10
pubmed: 12867109
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1277-1282
pubmed: 27694497
Neurosurgery. 2013 Sep;73(3):497-505
pubmed: 23756745
J Neurosurg. 2014 Dec;121(6):1367-73
pubmed: 25216063
Mediators Inflamm. 2012;2012:271582
pubmed: 23316103
AJNR Am J Neuroradiol. 2006 Mar;27(3):504-12
pubmed: 16551985
J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):122-128
pubmed: 33097563
J Neurointerv Surg. 2018 Jul;10(Suppl 1):i58-i67
pubmed: 30037960
J Neurosurg. 2016 Jan;124(1):45-50
pubmed: 26162033
Neurology. 2012 Sep 18;79(12):1230-6
pubmed: 22955127
Hypertension. 2016 Aug;68(2):312-4
pubmed: 27296992
Stroke. 2014 Feb;45(2):579-86
pubmed: 24370755
Stroke. 2014 Jul;45(7):1958-63
pubmed: 24851875
Neurosurg Focus. 2019 Jul 1;47(1):E17
pubmed: 31261121
Lancet Neurol. 2014 Jan;13(1):59-66
pubmed: 24290159
J Neurosurg. 2019 Dec 27;:1-14
pubmed: 31881533
Stroke. 2013 Sep;44(9):2414-21
pubmed: 23868274
BMJ Open. 2013 Aug 30;3(8):e003423
pubmed: 23996822
Acta Neurochir (Wien). 2020 Mar;162(3):553-566
pubmed: 32008209
Swiss Med Wkly. 2016 Jul 11;146:w14323
pubmed: 27399797
Stroke. 2010 Aug;41(8):e519-36
pubmed: 20595669
Stroke. 2005 Nov;36(11):2394-9
pubmed: 16210556
Lancet. 2019 Aug 24;394(10199):639-651
pubmed: 31327564
Stroke. 2013 Nov;44(11):3018-26
pubmed: 23899912
NCHS Data Brief. 2017 Oct;(289):1-8
pubmed: 29155682
Neurology. 2009 Jan 6;72(1):69-72
pubmed: 19122033
Stroke. 2007 Apr;38(4):1404-10
pubmed: 17332442
J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):4-7
pubmed: 20667856
Neurology. 2017 Sep 26;89(13):1408-1415
pubmed: 28855408
Stroke. 2021 Jan;52(1):344-347
pubmed: 33272133
Stroke. 2017 Aug;48(8):2105-2112
pubmed: 28667020
PLoS One. 2018 Jul 6;13(7):e0200010
pubmed: 29979744
Biomech Model Mechanobiol. 2017 Feb;16(1):97-115
pubmed: 27440126
Nat Genet. 2020 Dec;52(12):1303-1313
pubmed: 33199917
Stroke. 2016 May;47(5):1219-26
pubmed: 27073241
N Engl J Med. 2017 Jul 20;377(3):257-266
pubmed: 28723321